Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0 of 8 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(55.6%)

Phase 2

2(22.2%)

Phase 4

2(22.2%)

9Total

N/A(5)

Phase 2(2)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06549556Phase 2Completed

The Value of Using Colostrum Supplements on the Physical Performance and Cognitive Function in Healthy Subjects and Type 2 Diabetes

Role: lead

NCT06454643Not ApplicableCompleted

Gentamicin in Cardiac Surgery

Role: lead

NCT06022640Not ApplicableCompleted

Educational and Supportive Care to Depressed Infertile Females

Role: lead

NCT05981742Phase 2Completed

Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS

Role: lead

NCT05918068Not ApplicableCompleted

Pyridoxine Effect on the Blood Glucose Level in Type 2 Diabetic Patients

Role: lead

NCT04348006Phase 4Withdrawn

Assessment of Bortezomib (Alvocade ®) Efficacy and Safety in Newly Diagnosed Multiple Myeloma Patients

Role: lead

NCT04477421Not ApplicableCompleted

Femtosecond Small Incision Lenticular Extraction in Comparison to Femtosecond Laser Insitu Keratomileusis Regarding Dry Eye Disease

Role: lead

NCT04418986Phase 4Completed

Incisional Correction of Corneal Astigmatism During Phacoemulsification

Role: lead

NCT04319029Not ApplicableCompleted

Assessment of Dyslipidemic Patients' Knowledge, Quality of Life, and Adherence

Role: lead

All 9 trials loaded